Evidence map›Paper›PMID 33158826›Full record

ArticleBMJ open2020

Using discrete choice experiments to design interventions for heterogeneous preferences: protocol for a pragmatic randomised controlled trial of a preference-informed, heterogeneity-focused, HIV testing offer for high-risk populations.

Jan Ostermann, Bernard Njau, Amy Hobbie, Tara Mtuy, Martha L Masaki, Aisa Shayo, Marco van Zwetselaar, Max Masnick, Brian Flaherty, Derek S Brown and 2 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02714140 (Does Preference-based HIV Testing Increase Uptake in High Risk Populations?), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02714140 nacompletednot on this map

Does Preference-based HIV Testing Increase Uptake in High Risk Populations?

TypeinterventionalSponsorUniversity of South CarolinaRan2018 to 2020Enrolled1,194ConditionsHIV TestingArmsPB-HCT +, PB-HCT -, Economic incentive, PB-HCT ++, SMS Reminder
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jan OstermannDepartment of Health Services Policy & Management, University of South Carolina, Columbia, South Carolina, USA jano@mailbox.sc.edu.ORCID 0000-0002-8236-9500
Bernard NjauKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Amy HobbieDuke Global Health Institute, Duke University, Durham, North Carolina, USA.
Tara MtuyKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Martha L MasakiKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Aisa ShayoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Marco van ZwetselaarKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID 0000-0002-5953-0060
Max MasnickSelway Labs, LLC, Barrington, Rhode Island, USA.
Brian FlahertyDepartment of Psychology, University of Washington, Seattle, Washington, USA.
Derek S BrownBrown School, Washington University in St. Louis, St. Louis, Missouri, USA.
Axel C MühlbacherCenter for Health Policy & Inequalities Research, Duke University, Durham, North Carolina, USA.
Nathan M ThielmanDuke Global Health Institute, Duke University, Durham, North Carolina, USA.

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Does preference-based HIV testing increase uptake in high risk populations?R01MH106388 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI OSTERMANN, JAN, THIELMAN, NATHAN M · 2015 to 2019
$2.8M
NIAID NIH HHS P30 AI064518NIMH NIH HHS R01 MH106388
6 · The paper itself

Abstract

introductionApproximately one million undiagnosed persons living with HIV in Southern and Eastern Africa need to test for HIV. Novel approaches are necessary to identify HIV testing options that match the heterogeneous testing preferences of high-risk populations. This pragmatic randomised controlled trial (PRCT) will evaluate the efficacy of a preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer, for improving rates of HIV testing in two high-risk populations. METHODS AND ANALYSIS: The study will be conducted in Moshi, Tanzania. The PRCT will randomise 600 female barworkers and 600 male Kilimanjaro mountain porters across three study arms. All participants will receive an HIV testing offer comprised of four preference-informed testing options, including one 'common' option-comprising features that are commonly available in the area and, on average, most preferred among study participants-and three options that are specific to the study arm. Options will be identified using mixed logit and latent class analyses of data from a discrete choice experiment (DCE). Participants in Arm 1 will be offered the common option and three 'targeted' options that are predicted to be more preferred than the common option and combine features widely available in the study area. Participants in Arm 2 will be offered the common option and three 'enhanced' options, which also include HCT features that are not yet widely available in the study area. Participants in Arm 3, an active control arm, will be offered the common option and three predicted 'less preferred' options. The primary outcome will be uptake of HIV testing. ETHICS AND DISSEMINATION: Ethical approval was obtained from the Duke University Health System IRB, the University of South Carolina IRB, the Ethics Review Committee at Kilimanjaro Christian Medical University College, Tanzania's National Institute for Medical Research, and the Tanzania Food & Drugs Authority (now Tanzania Medicines & Medical Devices Authority). Findings will be published in peer-reviewed journals. The use of rigorous DCE methods for the preference-based design and tailoring of interventions could lead to novel policy options and implementation science approaches. TRIAL REGISTRATION NUMBER: NCT02714140.

Indexed as

HIV InfectionsHIV TestingCounselingFemaleHumansMalePragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicTanzaniahealth economicshiv & aidspublic healthstatistics & research methods

Identifiers

PMID33158826
PMCPMC7651730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.